In 2002 a published double blind clinical study undertaken to examine the utility of HairGenesis® demonstrated safety and efficacy in a botanically-based, natural hair loss treatment.  This was the first time a naturally-derived hair loss treatment was proven to work.  Saw palmetto extract was one of the active ingredients used in the 2002 HairGenesis® formula, proven in this study.

In our previous segment we touched on the various forms of hair loss that commonly occur. As we discussed, the most common cause of hair loss is hereditary baldness, or androgenetic alopecia (AGA) also known as male pattern baldness. We also touched upon other less-common causes of hair loss including disorders which may be linked to underlying diseases, medications, medical treatments, normal hormonal changes, stress, and poor nutrition.

What Are The Causes Of Hair Loss?

The most common cause of hair loss is hereditary baldness, or androgenetic alopecia (AGA) also known as male pattern baldness.  Strikingly, as we age pattern hair loss may ultimately affect almost as many women as men. Other less-common causes of hair loss include disorders which may be linked to underlying diseases, medications, medical treatments, normal hormonal changes, stress, and poor nutrition.

Having spent the better part of two decades investing a great deal of effort to infuse our product line with credibility and validity, we are regularly taken aback by the proliferation of swampy used-car-salesman-like tactics some of our competitors use to peddle their products.  Now we certainly understand that not everyone has the training, expertise and motivation to rise to the level of service that we provide at HairGenesis®, but neither can we comprehend the outright lies, distortions, misstatements and other such nonsense proliferating in this industry.  

Until recently, scientifically-validated hair loss treatments consisted entirely of compositions formulated to block a key precursor enzyme (5 alpha-reductase).  This enzyme precipitates the conversion of testosterone (T) to dihydrotestosterone (DHT).  DHT has been compellingly and repeatedly demonstrated to represent an important negative factor in the onset and progression of pattern hair loss, also known as androgenetic alopecia (AGA).

In the maintenance of human health, systems have been designed in us to surveil and deal aggressively with invasion by pathogens such as bacteria, viruses, helminths etc.  Likewise, our bodies have been designed to detect and weed out rapid out-of-control cell growth because this generally signals the onset of cancer.  

Sometimes however, the surveillance mechanisms can be overly sensitive, leading to the diseases of autoimmunity.  Examples of such disease includes type 1 diabetes, rheumatoid arthritis, alopecia areata and lupus erythematosis.  Here, instead of protecting us against outside attack, the body, in a manner of speaking, attacks itself.  Microscopic photographs of autoimmune lesions contain white blood cells which have been described as a swarm of bees.  

A consumer concerned about alopecia areata type hair loss writes:  Does HairGenesis® work in the setting of alopecia areata (AA) as well as for other forms of hair loss?  Here's my response:

Your e-mail was forwarded to my attention so I hope you do not mind if I reply personally.  I should preface my comments by noting that I am a Ph.D. research scientist, NOT an M.D. clinician.  This means that any thoughts I offer in this regard should not be construed as medical advice.  As long as we both appreciate the limitations of what I've just conveyed, here are my thoughts.

For people concerned about hair loss, many myths and half-truths abound, but useful information can be difficult to put your hands on. Therefore, an objective overview of pattern hair loss is desirable.  

In healthy well-nourished males and females the most common form of hair loss is androgenetic alopecia (AGA), also known as pattern hair loss. The disorder affects approximately 40 million American men.  It may be a shock to learn that common pattern hair loss affects 20 million American women. The difference between the genders is that a woman suffering hair loss usually retains her juvenile hairline but experiences loss of density behind the leading edge. In men, a distinct pattern manifests where the frontal hair line recedes at the same time that a thinning zone expands from the posterior crown. In more pronounced cases, these zones meet and the person is said to be clinically bald.